and J. Moon, "Pitavastatin for the treatment of primary hyperlipidemia and mixed dyslipidemia," Expert Review of Cardiovascular Therapy, vol. 8, no. 8, pp. 1079-1090, 2010.Gotto AM,Moon J.Pitavasta tin for the treatment ofprimary hyperlipidemia and mixed dyslipidemia. Ex-pert Rev Cardiovasc...
Primary Hyperlipidemia and Mixed DyslipidemiaDrug TrialsShow entriesDrugDrug NamePhaseStatusCount DB01076 Atorvastatin 3 Completed 1 DB09303 Evolocumab 3 Completed 1 Showing 1 to 2 of 2 entries ‹ 1 › Stay up-to-date with the latest from DrugBank! Subscribe Downloads Data Library Academic...
Micronized fenofibrate may be considered an effective first-line therapy for patients with primary hyperlipidemia, particularly those with type IIb mixed dyslipidemia or type 2 diabetes. 展开 关键词: Keyword Highlighting Highlight selected keywords in the article text ...
Dyslipidemia is a major modifiable risk factor for CVD. It can be classified into hypercholesterolemia, hypertriglyceridemia, and mixed hyperlipidemia, characterized by elevated levels of either total cholesterol (TC) or triglycerides (TG), or a combined pattern. This condition is linked to an underlyi...
Atorvastatin in the treatment of primary hypercholesterolemia and mixed dyslipidemias OBJECTIVE: To review the efficacy and safety of atorvastatin in the treatment of dyslipidemias. DATA SOURCES: A MEDLINE search (January 1960-April 1998), C... Yee,H. - 《Annals of Pharmacotherapy》 被引量: 82...
Efficacy and Safety of the Coadministration of Ezetimibe/Simvastatin with Fenofibrate in Patients with Mixed Hyperlipidemia. Am. Heart J. 2007, 153, 335.e1–335.e8. [Google Scholar] [CrossRef] Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are ...